A Randomized Comparison Study Assessing the Impact of Cilostazol on the Heart Rate and Arrhythmias by 24-Hour Ambulatory Holter Electrocardiographic Monitoring after Drug-Eluting Stent Implantation for Coronary Artery Disease-Reference-Cited by-同舟云学术

A Randomized Comparison Study Assessing the Impact of Cilostazol on the Heart Rate and Arrhythmias by 24-Hour Ambulatory Holter Electrocardiographic Monitoring after Drug-Eluting Stent Implantation for Coronary Artery Disease

Published:2015 Issue:2 Volume:22 Page:152-164
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kwon Beom-June¹,Lee Su-Hyun²,Kim Dong-Bin²,Park Hun-Jun²,Jang Sung-Won²,Ihm Sang-Hyun²,Kim Hee-Yeol²,Seung Ki-Bae²

Affiliation:

1. Department of Cardiology, Seogwipo Medical Center, Jeju, Republic of Korea

2. Department of Cardiology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Reference44 articles.

1. 1) Jouven X, Empana J, Escolano S, Buyck J, Tafflet M, Desnos M, DucimetiÃƒre P: Relation of heart rate at rest and long-term (＞20 years) death rate in initially healthy middle-aged men. Am J Cardiol, 2009; 103: 279-283

2. 2) Kolloch R, Legler U, Champion A, Cooper Dehoff R, Handberg E, Zhou Q, Pepine C: Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J, 2008; 29: 1327-1334

3. 3) Fox K, Ford I, Steg PG, Tendera M, Ferrari R: Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2008; 372: 807-816

4. 4) Cucherat M: Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J, 2007; 28: 3012-3019

5. 5) Jouven X, Empana J-P, Schwartz P, Desnos M, Courbon D, DucimetiÃƒre P: Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med, 2005; 352: 1951-1958

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cilostazol treats transient heart failure caused by ATP1A3 variant-associated polymicrogyria;Brain and Development;2024-01

2. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

3. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

4. Cilostazol for Secondary Stroke Prevention;Stroke;2021-10

5. Solubility Measurement and the Correlation of Cilostazol in Pure and 1,4-Dioxane + Ethanol Binary Solvents from T = 273.15 to 313.15 K;Journal of Chemical & Engineering Data;2021-06-29